fda removing semaglutide What happens when a breakthrough medication goes mainstream? 💉 Using national poison control data, UT San Antonio researchers uncover a dramatic rise in semaglutide-related calls following approval for weight management. Read FDA approves obesity drug that

METHODS To provide a robust evidence base for the workshop discussions, a comprehensive literature search was conducted using databases such as PubMed, EMBASE, and the Cochrane Library

Neuroprotective Effects- Glutathione protects brain cells from oxidative damage and inflammation, potentially reducing the risk of neurodegenerative diseases like Alzheimers and Parkinsons

C.LamanJ

Telehealth Consultation You will be assigned a US-based physician as part of the onboarding process

These randomized controlled trials demonstrated that tirzepatide produced significant reductions in the apnea-hypopnea index (AHI)the primary metric for OSA severitycompared to placebo

Expanding GLP-1 Indications Beyond Obesity and Diabetes While obesity and type 2 diabetes remain the primary targets for GLP-1 drugs, there is growing interest in expanding the use of these drugs to treat other metabolic and cardiovascular conditions